Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02354131
Title Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Nordic Society for Gynaecologic Oncology

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer



Bevacizumab + Niraparib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.